| | | | | | | |
 | JOHNSON & JOHNSON | -0.01% | -1.58% | -0.52% | -2.03% | 28.89% | 447 434 |
| ELI LILLY AND COMPANY | 0.17% | -5.37% | 9.70% | 13.42% | 166.34% | 287 922 |
| PFIZER, INC. | 0.42% | -2.05% | -15.70% | 8.26% | 36.95% | 279 310 |
 | ROCHE HOLDING AG | 0.79% | 0.14% | -16.02% | -12.14% | 17.00% | 275 991 |
| ABBVIE INC. | -0.06% | 0.09% | 3.58% | 22.96% | 113.86% | 247 976 |
 | NOVO NORDISK A/S | 2.19% | -11.46% | 4.27% | 20.35% | 129.46% | 238 658 |
| MERCK & CO., INC. | 1.16% | 2.18% | 16.81% | 18.85% | 4.68% | 226 779 |
 | ASTRAZENECA PLC | 1.19% | 0.58% | 24.94% | 32.30% | 47.49% | 203 058 |
| NOVARTIS AG | 1.19% | 0.70% | 3.71% | -1.64% | -5.64% | 190 668 |
| BRISTOL-MYERS SQUIBB COMPANY | 1.57% | 0.24% | 20.22% | 11.25% | 58.41% | 160 059 |
| AMGEN INC. | 0.43% | 1.82% | 10.40% | 8.98% | 26.55% | 132 855 |
| GSK PLC | -0.76% | -2.84% | -18.00% | -9.04% | -21.10% | 80 582 |
 | BAYER AG | -1.49% | -10.07% | 10.98% | 10.50% | -19.29% | 52 412 |
 | DAIICHI SANKYO CO., LTD. | 1.22% | 6.43% | 24.62% | 74.15% | 53.04% | 51 146 |
| CHUGAI PHARMACEUTICAL CO., LTD | 0.00% | -0.42% | 1.29% | -7.19% | 53.16% | 46 111 |
| | | | | | | |
| | Gemiddelde | 0.53% | -1.44% | 5.35% | 12.60% | 45.99% | |
| | Gewogen gemiddelde per kap. | 0.63% | -1.68% | 3.53% | 10.02% | 54.75% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Rapport
